Key points

L-GF uses a standardized number of allogenic pathogen-free platelets instead of autologous platelets used in PRP as a source of growth factors.L-GF injection in patients with SIS has resulted in significant improvement both clinically and sonographically, signifying its potential beneficial effects on tendon healing.L-GF injection could be a mini-invasive intervention for SIS treatment that gives hopeful results.